{
  "id": [
    "30864265"
  ],
  "source": [
    "MED"
  ],
  "pmid": [
    "30864265"
  ],
  "pmcid": [
    "PMC6465231"
  ],
  "doi": [
    "10.1111/1751-7915.13388"
  ],
  "title": [
    "Dismantling the bacterial virulence program."
  ],
  "authorString": [
    "Alford MA, Pletzer D, Hancock REW."
  ],
  "authorList": [
    {
      "author": [
        {
          "fullName": [
            "Alford MA"
          ],
          "firstName": [
            "Morgan A"
          ],
          "lastName": [
            "Alford"
          ],
          "initials": [
            "MA"
          ],
          "authorId": [
            {
              "_": "0000-0002-4446-817X",
              "$": {
                "type": "ORCID"
              }
            }
          ],
          "affiliation": [
            "Centre for Microbial Diseases and Immunity Research, Department of Microbiology and Immunology, University of British Columbia, Vancouver, BC, Canada."
          ]
        },
        {
          "fullName": [
            "Pletzer D"
          ],
          "firstName": [
            "Daniel"
          ],
          "lastName": [
            "Pletzer"
          ],
          "initials": [
            "D"
          ],
          "authorId": [
            {
              "_": "0000-0001-5750-7505",
              "$": {
                "type": "ORCID"
              }
            }
          ],
          "affiliation": [
            "Centre for Microbial Diseases and Immunity Research, Department of Microbiology and Immunology, University of British Columbia, Vancouver, BC, Canada."
          ]
        },
        {
          "fullName": [
            "Hancock REW"
          ],
          "firstName": [
            "Robert E W"
          ],
          "lastName": [
            "Hancock"
          ],
          "initials": [
            "REW"
          ],
          "authorId": [
            {
              "_": "0000-0001-5989-8503",
              "$": {
                "type": "ORCID"
              }
            }
          ],
          "affiliation": [
            "Centre for Microbial Diseases and Immunity Research, Department of Microbiology and Immunology, University of British Columbia, Vancouver, BC, Canada."
          ]
        }
      ]
    }
  ],
  "authorIdList": [
    {
      "authorId": [
        {
          "_": "0000-0001-5750-7505",
          "$": {
            "type": "ORCID"
          }
        },
        {
          "_": "0000-0001-5989-8503",
          "$": {
            "type": "ORCID"
          }
        },
        {
          "_": "0000-0002-4446-817X",
          "$": {
            "type": "ORCID"
          }
        }
      ]
    }
  ],
  "journalInfo": [
    {
      "issue": [
        "3"
      ],
      "volume": [
        "12"
      ],
      "journalIssueId": [
        "2806569"
      ],
      "dateOfPublication": [
        "2019 May"
      ],
      "monthOfPublication": [
        "5"
      ],
      "yearOfPublication": [
        "2019"
      ],
      "printPublicationDate": [
        "2019-05-01"
      ],
      "journal": [
        {
          "title": [
            "Microbial biotechnology"
          ],
          "ISOAbbreviation": [
            "Microb Biotechnol"
          ],
          "medlineAbbreviation": [
            "Microb Biotechnol"
          ],
          "NLMid": [
            "101316335"
          ],
          "ISSN": [
            "1751-7915"
          ],
          "ESSN": [
            "1751-7915"
          ]
        }
      ]
    }
  ],
  "pubYear": [
    "2019"
  ],
  "pageInfo": [
    "409-413"
  ],
  "abstractText": [
    "In the face of rising antimicrobial resistance, there is an urgent need for the development of efficient and effective anti-infective compounds. Adaptive resistance, a reversible bacterial phenotype characterized by the ability to surmount antibiotic challenge without mutation, is triggered to cope in situ with several stressors and is very common clinically. Thus, it is important to target stress-response effectors that contribute to in vivo adaptations and associated lifestyles such as biofilm formation. Interfering with these proteins should provide a means of dismantling bacterial virulence for treating infectious diseases, in combination with conventional antibiotics."
  ],
  "affiliation": [
    "Centre for Microbial Diseases and Immunity Research, Department of Microbiology and Immunology, University of British Columbia, Vancouver, BC, Canada."
  ],
  "language": [
    "eng"
  ],
  "pubModel": [
    "Print-Electronic"
  ],
  "pubTypeList": [
    {
      "pubType": [
        "article-commentary",
        "Research Support, Non-U.S. Gov't",
        "Journal Article"
      ]
    }
  ],
  "grantsList": [
    {
      "grant": [
        {
          "grantId": [
            "FDN-154287"
          ],
          "agency": [
            "CIHR"
          ],
          "orderIn": [
            "0"
          ]
        }
      ]
    }
  ],
  "meshHeadingList": [
    {
      "meshHeading": [
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Bacteria"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "GD"
                  ],
                  "qualifierName": [
                    "growth & development"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                },
                {
                  "abbreviation": [
                    "PY"
                  ],
                  "qualifierName": [
                    "pathogenicity"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Virulence Factors"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "AI"
                  ],
                  "qualifierName": [
                    "antagonists & inhibitors"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "ME"
                  ],
                  "qualifierName": [
                    "metabolism"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Anti-Bacterial Agents"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "IP"
                  ],
                  "qualifierName": [
                    "isolation & purification"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "PD"
                  ],
                  "qualifierName": [
                    "pharmacology"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Adaptation, Physiological"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Virulence"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Host-Pathogen Interactions"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Stress, Physiological"
          ]
        }
      ]
    }
  ],
  "chemicalList": [
    {
      "chemical": [
        {
          "name": [
            "Anti-Bacterial Agents"
          ],
          "registryNumber": [
            "0"
          ]
        },
        {
          "name": [
            "Virulence Factors"
          ],
          "registryNumber": [
            "0"
          ]
        }
      ]
    }
  ],
  "subsetList": [
    {
      "subset": [
        {
          "code": [
            "IM"
          ],
          "name": [
            "Index Medicus"
          ]
        }
      ]
    }
  ],
  "fullTextUrlList": [
    {
      "fullTextUrl": [
        {
          "availability": [
            "Subscription required"
          ],
          "availabilityCode": [
            "S"
          ],
          "documentStyle": [
            "doi"
          ],
          "site": [
            "DOI"
          ],
          "url": [
            "https://doi.org/10.1111/1751-7915.13388"
          ]
        },
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "html"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "http://europepmc.org/articles/PMC6465231"
          ]
        },
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "pdf"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "http://europepmc.org/articles/PMC6465231?pdf=render"
          ]
        }
      ]
    }
  ],
  "isOpenAccess": [
    "Y"
  ],
  "inEPMC": [
    "Y"
  ],
  "inPMC": [
    "N"
  ],
  "hasPDF": [
    "Y"
  ],
  "hasBook": [
    "N"
  ],
  "hasSuppl": [
    "N"
  ],
  "citedByCount": [
    "0"
  ],
  "hasData": [
    "N"
  ],
  "hasReferences": [
    "Y"
  ],
  "hasTextMinedTerms": [
    "Y"
  ],
  "hasDbCrossReferences": [
    "N"
  ],
  "hasLabsLinks": [
    "Y"
  ],
  "license": [
    "cc by"
  ],
  "authMan": [
    "N"
  ],
  "epmcAuthMan": [
    "N"
  ],
  "nihAuthMan": [
    "N"
  ],
  "hasTMAccessionNumbers": [
    "N"
  ],
  "dateOfCompletion": [
    "2019-06-10"
  ],
  "dateOfCreation": [
    "2019-03-14"
  ],
  "firstIndexDate": [
    "2019-03-14"
  ],
  "fullTextReceivedDate": [
    "2019-04-25"
  ],
  "dateOfRevision": [
    "2019-06-13"
  ],
  "electronicPublicationDate": [
    "2019-03-12"
  ],
  "firstPublicationDate": [
    "2019-03-12"
  ]
}